| 
																	
																	
																		 Wendy Nembhard
 
																		 Concepts  (362)
																		
																	 
																		Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months. 
																			
																					
    Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
     | Name | Number of Publications | Most Recent Publication | Publications by All Authors | Concept Score | Why? | 
|---|
 | Heart Defects, Congenital | 50 | 2025 | 619 | 9.340 | Why? |  | Congenital Abnormalities | 22 | 2025 | 118 | 6.300 | Why? |  | Registries | 29 | 2025 | 581 | 3.220 | Why? |  | Stillbirth | 12 | 2024 | 29 | 3.130 | Why? |  | Population Surveillance | 17 | 2024 | 165 | 2.600 | Why? |  | Infant | 57 | 2025 | 3733 | 2.530 | Why? |  | Infant, Newborn | 50 | 2025 | 2867 | 2.290 | Why? |  | Gastroschisis | 7 | 2024 | 39 | 2.090 | Why? |  | Pregnancy | 52 | 2025 | 2680 | 2.060 | Why? |  | Female | 113 | 2025 | 28171 | 1.970 | Why? |  | Prevalence | 29 | 2025 | 1006 | 1.750 | Why? |  | Humans | 138 | 2025 | 52483 | 1.710 | Why? |  | Genetic Predisposition to Disease | 10 | 2025 | 528 | 1.660 | Why? |  | Adult | 56 | 2025 | 14161 | 1.580 | Why? |  | Infant Mortality | 8 | 2024 | 61 | 1.520 | Why? |  | United States | 39 | 2025 | 5192 | 1.440 | Why? |  | Hypospadias | 5 | 2022 | 36 | 1.390 | Why? |  | Child | 40 | 2025 | 7248 | 1.390 | Why? |  | Case-Control Studies | 25 | 2025 | 1201 | 1.290 | Why? |  | Young Adult | 30 | 2025 | 4329 | 1.280 | Why? |  | Risk Factors | 33 | 2025 | 3889 | 1.240 | Why? |  | Cesarean Section | 3 | 2021 | 184 | 1.240 | Why? |  | Male | 68 | 2025 | 26761 | 1.230 | Why? |  | Child Mortality | 5 | 2020 | 12 | 1.190 | Why? |  | Esophageal Atresia | 3 | 2024 | 6 | 1.140 | Why? |  | Infant, Small for Gestational Age | 4 | 2020 | 35 | 1.140 | Why? |  | Child, Preschool | 24 | 2025 | 4076 | 1.140 | Why? |  | Transposition of Great Vessels | 4 | 2024 | 26 | 1.060 | Why? |  | Cohort Studies | 13 | 2025 | 1542 | 1.060 | Why? |  | Maternal Exposure | 9 | 2024 | 103 | 1.050 | Why? |  | Retrospective Studies | 31 | 2023 | 6607 | 1.030 | Why? |  | Arkansas | 13 | 2025 | 2028 | 1.030 | Why? |  | Occupational Exposure | 2 | 2025 | 111 | 1.020 | Why? |  | Hernia, Umbilical | 4 | 2024 | 22 | 0.980 | Why? |  | Tracheoesophageal Fistula | 2 | 2024 | 11 | 0.960 | Why? |  | Prenatal Exposure Delayed Effects | 4 | 2021 | 197 | 0.960 | Why? |  | Gestational Age | 8 | 2022 | 417 | 0.960 | Why? |  | Adolescent | 26 | 2025 | 6739 | 0.950 | Why? |  | Poultry | 1 | 2025 | 29 | 0.950 | Why? |  | Life Expectancy | 1 | 2025 | 34 | 0.940 | Why? |  | Healthcare Disparities | 5 | 2025 | 299 | 0.920 | Why? |  | Lamin Type A | 1 | 2024 | 6 | 0.900 | Why? |  | Occupational Diseases | 1 | 2025 | 85 | 0.890 | Why? |  | Intellectual Disability | 2 | 2023 | 127 | 0.860 | Why? |  | Esophageal Neoplasms | 1 | 2025 | 111 | 0.850 | Why? |  | Public Health | 2 | 2024 | 223 | 0.850 | Why? |  | Educational Status | 6 | 2025 | 226 | 0.840 | Why? |  | Pregnancy Outcome | 5 | 2024 | 250 | 0.840 | Why? |  | Policy | 1 | 2023 | 27 | 0.810 | Why? |  | Prenatal Diagnosis | 6 | 2021 | 103 | 0.800 | Why? |  | DNA Methylation | 2 | 2024 | 592 | 0.780 | Why? |  | Delivery, Obstetric | 3 | 2020 | 122 | 0.770 | Why? |  | Autistic Disorder | 2 | 2023 | 126 | 0.760 | Why? |  | Insurance, Health | 1 | 2023 | 131 | 0.750 | Why? |  | Length of Stay | 1 | 2025 | 663 | 0.740 | Why? |  | Dietary Supplements | 2 | 2025 | 465 | 0.740 | Why? |  | Insurance Coverage | 1 | 2023 | 115 | 0.740 | Why? |  | Proportional Hazards Models | 10 | 2025 | 443 | 0.730 | Why? |  | Genetic Variation | 3 | 2021 | 230 | 0.720 | Why? |  | Placenta | 1 | 2022 | 153 | 0.710 | Why? |  | Live Birth | 11 | 2022 | 24 | 0.710 | Why? |  | Health Status Disparities | 3 | 2013 | 215 | 0.700 | Why? |  | Health Services Accessibility | 3 | 2023 | 436 | 0.700 | Why? |  | Hypoplastic Left Heart Syndrome | 3 | 2023 | 98 | 0.700 | Why? |  | Hospitals, Teaching | 1 | 2020 | 54 | 0.690 | Why? |  | Tobacco, Smokeless | 1 | 2020 | 24 | 0.680 | Why? |  | Hospitalization | 1 | 2025 | 736 | 0.680 | Why? |  | Abnormalities, Radiation-Induced | 1 | 2019 | 7 | 0.640 | Why? |  | Hospitals | 1 | 2020 | 182 | 0.630 | Why? |  | Nicotine | 1 | 2020 | 180 | 0.630 | Why? |  | Down Syndrome | 4 | 2025 | 93 | 0.620 | Why? |  | Tobacco Products | 1 | 2020 | 127 | 0.600 | Why? |  | Middle Aged | 18 | 2025 | 13028 | 0.590 | Why? |  | Premature Birth | 3 | 2020 | 153 | 0.560 | Why? |  | Abnormalities, Drug-Induced | 1 | 2017 | 18 | 0.540 | Why? |  | Heart Septal Defects | 1 | 2016 | 14 | 0.530 | Why? |  | Texas | 9 | 2024 | 143 | 0.510 | Why? |  | Maternal Age | 10 | 2024 | 45 | 0.500 | Why? |  | Air Pollutants | 4 | 2021 | 75 | 0.500 | Why? |  | Tetralogy of Fallot | 1 | 2016 | 86 | 0.490 | Why? |  | Emergency Treatment | 1 | 2015 | 28 | 0.480 | Why? |  | Kaplan-Meier Estimate | 7 | 2024 | 483 | 0.480 | Why? |  | Developed Countries | 1 | 2015 | 17 | 0.480 | Why? |  | Hysterectomy | 1 | 2015 | 90 | 0.470 | Why? |  | Postpartum Hemorrhage | 1 | 2015 | 39 | 0.460 | Why? |  | Limb Deformities, Congenital | 2 | 2025 | 15 | 0.460 | Why? |  | Genome-Wide Association Study | 4 | 2023 | 186 | 0.450 | Why? |  | Odds Ratio | 12 | 2024 | 558 | 0.440 | Why? |  | Thoracic Surgery | 1 | 2013 | 22 | 0.420 | Why? |  | Neural Tube Defects | 2 | 2023 | 33 | 0.420 | Why? |  | Western Australia | 4 | 2023 | 6 | 0.420 | Why? |  | Neoplasms | 2 | 2020 | 1325 | 0.420 | Why? |  | Birth Weight | 2 | 2010 | 125 | 0.410 | Why? |  | Urinary Tract Infections | 2 | 2023 | 57 | 0.400 | Why? |  | Infant, Premature, Diseases | 2 | 2017 | 94 | 0.390 | Why? |  | Kidney Neoplasms | 2 | 2025 | 182 | 0.390 | Why? |  | Exome | 4 | 2025 | 55 | 0.380 | Why? |  | Cleft Palate | 2 | 2023 | 79 | 0.380 | Why? |  | Liver Neoplasms | 3 | 2025 | 333 | 0.370 | Why? |  | Cause of Death | 4 | 2025 | 160 | 0.370 | Why? |  | Australia | 3 | 2023 | 89 | 0.370 | Why? |  | Polymorphism, Single Nucleotide | 6 | 2022 | 505 | 0.370 | Why? |  | Birth Certificates | 2 | 2021 | 26 | 0.360 | Why? |  | Cross-Sectional Studies | 5 | 2025 | 1678 | 0.360 | Why? |  | Anophthalmos | 2 | 2022 | 4 | 0.350 | Why? |  | Florida | 5 | 2019 | 67 | 0.350 | Why? |  | Microphthalmos | 2 | 2022 | 7 | 0.350 | Why? |  | Comorbidity | 5 | 2025 | 625 | 0.340 | Why? |  | Air Pollution | 3 | 2019 | 49 | 0.340 | Why? |  | Age Factors | 3 | 2025 | 1132 | 0.340 | Why? |  | Turner Syndrome | 2 | 2023 | 15 | 0.340 | Why? |  | Aged | 7 | 2025 | 10121 | 0.330 | Why? |  | Risk Assessment | 7 | 2021 | 1327 | 0.330 | Why? |  | Contraception | 3 | 2025 | 29 | 0.330 | Why? |  | Spinal Dysraphism | 2 | 2020 | 38 | 0.320 | Why? |  | Ultrasonography, Prenatal | 3 | 2021 | 190 | 0.320 | Why? |  | Survival Rate | 7 | 2024 | 945 | 0.320 | Why? |  | Micronesia | 2 | 2019 | 112 | 0.310 | Why? |  | Counseling | 3 | 2025 | 136 | 0.300 | Why? |  | Reproductive Health | 2 | 2025 | 8 | 0.290 | Why? |  | Incidence | 3 | 2023 | 1062 | 0.280 | Why? |  | Cardiology | 2 | 2023 | 97 | 0.270 | Why? |  | Disinfection | 2 | 2024 | 12 | 0.270 | Why? |  | Patient Acceptance of Health Care | 3 | 2025 | 358 | 0.260 | Why? |  | CpG Islands | 2 | 2024 | 121 | 0.260 | Why? |  | Hepatoblastoma | 2 | 2023 | 5 | 0.260 | Why? |  | Infant, Low Birth Weight | 2 | 2021 | 79 | 0.250 | Why? |  | Genotype | 4 | 2023 | 566 | 0.250 | Why? |  | Parturition | 3 | 2022 | 50 | 0.250 | Why? |  | Neuroblastoma | 2 | 2023 | 51 | 0.250 | Why? |  | Medicaid | 2 | 2025 | 264 | 0.240 | Why? |  | Biliary Atresia | 2 | 2023 | 9 | 0.240 | Why? |  | Mortality, Premature | 1 | 2025 | 12 | 0.240 | Why? |  | Disinfectants | 2 | 2024 | 11 | 0.240 | Why? |  | Aortic Coarctation | 2 | 2023 | 31 | 0.230 | Why? |  | Water Purification | 1 | 2024 | 10 | 0.230 | Why? |  | Drinking Water | 1 | 2024 | 13 | 0.230 | Why? |  | Alleles | 3 | 2023 | 276 | 0.230 | Why? |  | Water Pollutants, Chemical | 2 | 2024 | 54 | 0.220 | Why? |  | Employment | 1 | 2025 | 93 | 0.220 | Why? |  | Health Care Costs | 1 | 2025 | 174 | 0.220 | Why? |  | Analysis of Variance | 2 | 2019 | 554 | 0.220 | Why? |  | Time Factors | 4 | 2025 | 2968 | 0.220 | Why? |  | Glaucoma | 1 | 2024 | 34 | 0.220 | Why? |  | Household Products | 1 | 2023 | 2 | 0.210 | Why? |  | Wilms Tumor | 1 | 2023 | 19 | 0.210 | Why? |  | Socioeconomic Factors | 5 | 2023 | 610 | 0.210 | Why? |  | Pregnancy Complications | 2 | 2019 | 400 | 0.210 | Why? |  | Thyroid Neoplasms | 1 | 2025 | 116 | 0.210 | Why? |  | Telemedicine | 2 | 2021 | 494 | 0.210 | Why? |  | Behavioral Risk Factor Surveillance System | 1 | 2023 | 28 | 0.200 | Why? |  | Medically Uninsured | 1 | 2023 | 46 | 0.200 | Why? |  | Anencephaly | 1 | 2022 | 15 | 0.200 | Why? |  | Fetal Death | 1 | 2022 | 24 | 0.200 | Why? |  | Mothers | 5 | 2023 | 270 | 0.200 | Why? |  | Autopsy | 1 | 2022 | 48 | 0.200 | Why? |  | Common Cold | 1 | 2022 | 5 | 0.200 | Why? |  | Cleft Lip | 1 | 2023 | 46 | 0.200 | Why? |  | Bladder Exstrophy | 1 | 2022 | 6 | 0.200 | Why? |  | Heart Septal Defects, Atrial | 1 | 2022 | 45 | 0.200 | Why? |  | Carcinoma, Hepatocellular | 1 | 2025 | 202 | 0.190 | Why? |  | Extreme Heat | 1 | 2021 | 3 | 0.190 | Why? |  | Birth Intervals | 1 | 2021 | 1 | 0.190 | Why? |  | Pyloric Stenosis, Hypertrophic | 1 | 2022 | 21 | 0.190 | Why? |  | Hydrocephalus | 1 | 2022 | 43 | 0.190 | Why? |  | Cluster Analysis | 1 | 2022 | 233 | 0.190 | Why? |  | Energy Intake | 2 | 2020 | 174 | 0.190 | Why? |  | Electronic Health Records | 1 | 2024 | 268 | 0.190 | Why? |  | Cataract | 2 | 2019 | 45 | 0.190 | Why? |  | Nitrogen Dioxide | 2 | 2019 | 7 | 0.180 | Why? |  | Influenza, Human | 1 | 2022 | 93 | 0.180 | Why? |  | Inheritance Patterns | 1 | 2021 | 22 | 0.180 | Why? |  | Students | 1 | 2023 | 228 | 0.180 | Why? |  | Disabled Persons | 1 | 2021 | 72 | 0.180 | Why? |  | Chromosome Disorders | 1 | 2021 | 32 | 0.180 | Why? |  | Term Birth | 1 | 2020 | 16 | 0.170 | Why? |  | Quality of Life | 3 | 2021 | 879 | 0.170 | Why? |  | Schools | 1 | 2021 | 172 | 0.160 | Why? |  | Digestive System Abnormalities | 1 | 2019 | 5 | 0.160 | Why? |  | Emotions | 1 | 2021 | 174 | 0.160 | Why? |  | Health Services | 1 | 2020 | 65 | 0.160 | Why? |  | Truncus Arteriosus | 1 | 2019 | 8 | 0.160 | Why? |  | Ozone | 1 | 2019 | 20 | 0.160 | Why? |  | Radioactive Hazard Release | 1 | 2019 | 14 | 0.160 | Why? |  | Gene Regulatory Networks | 1 | 2020 | 111 | 0.160 | Why? |  | Pregnancy, Multiple | 1 | 2019 | 23 | 0.160 | Why? |  | Diacylglycerol Kinase | 1 | 2019 | 5 | 0.160 | Why? |  | Urinalysis | 1 | 2019 | 33 | 0.160 | Why? |  | Logistic Models | 5 | 2023 | 925 | 0.160 | Why? |  | Fetal Diseases | 1 | 2020 | 61 | 0.160 | Why? |  | Gene-Environment Interaction | 1 | 2019 | 40 | 0.160 | Why? |  | Dietary Fats | 1 | 2020 | 130 | 0.160 | Why? |  | Substance Abuse Detection | 1 | 2019 | 89 | 0.160 | Why? |  | Chi-Square Distribution | 1 | 2019 | 288 | 0.150 | Why? |  | Cannabis | 1 | 2021 | 150 | 0.150 | Why? |  | Emigrants and Immigrants | 1 | 2019 | 37 | 0.150 | Why? |  | Abortion, Induced | 1 | 2018 | 22 | 0.150 | Why? |  | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 12 | 0.150 | Why? |  | Education, Medical, Graduate | 1 | 2020 | 219 | 0.150 | Why? |  | Multivariate Analysis | 1 | 2019 | 591 | 0.140 | Why? |  | Binge Drinking | 1 | 2018 | 24 | 0.140 | Why? |  | Genotyping Techniques | 1 | 2017 | 21 | 0.140 | Why? |  | Genetic Testing | 1 | 2018 | 129 | 0.140 | Why? |  | Smoking Cessation | 1 | 2020 | 315 | 0.140 | Why? |  | Eating | 1 | 2017 | 159 | 0.130 | Why? |  | Follow-Up Studies | 4 | 2023 | 2279 | 0.130 | Why? |  | Gastrointestinal Diseases | 1 | 2017 | 125 | 0.130 | Why? |  | Interviews as Topic | 1 | 2017 | 275 | 0.130 | Why? |  | Particulate Matter | 3 | 2021 | 63 | 0.120 | Why? |  | Peripartum Period | 1 | 2015 | 15 | 0.120 | Why? |  | Confidence Intervals | 2 | 2016 | 158 | 0.120 | Why? |  | Maternal Mortality | 1 | 2015 | 30 | 0.120 | Why? |  | Gene Expression Profiling | 1 | 2020 | 1105 | 0.120 | Why? |  | Residence Characteristics | 2 | 2014 | 159 | 0.120 | Why? |  | Diet | 1 | 2019 | 587 | 0.120 | Why? |  | Hypertension | 2 | 2014 | 565 | 0.110 | Why? |  | Starvation | 1 | 2014 | 11 | 0.110 | Why? |  | Sex Factors | 4 | 2017 | 727 | 0.110 | Why? |  | Public Health Surveillance | 1 | 2013 | 18 | 0.110 | Why? |  | Substance-Related Disorders | 1 | 2019 | 609 | 0.110 | Why? |  | Arizona | 2 | 2025 | 11 | 0.100 | Why? |  | Heart Diseases | 2 | 2014 | 216 | 0.100 | Why? |  | Survival Analysis | 2 | 2014 | 673 | 0.100 | Why? |  | Environmental Exposure | 3 | 2023 | 216 | 0.100 | Why? |  | Trihalomethanes | 2 | 2024 | 2 | 0.100 | Why? |  | Seroepidemiologic Studies | 2 | 2023 | 44 | 0.100 | Why? |  | Animals | 2 | 2025 | 13505 | 0.100 | Why? |  | Research Design | 1 | 2015 | 359 | 0.100 | Why? |  | Time-to-Treatment | 1 | 2013 | 78 | 0.100 | Why? |  | Poverty | 1 | 2014 | 219 | 0.100 | Why? |  | Pesticides | 1 | 2012 | 20 | 0.100 | Why? |  | Acculturation | 1 | 2012 | 21 | 0.100 | Why? |  | Respiratory Sounds | 1 | 2012 | 50 | 0.100 | Why? |  | Cough | 1 | 2012 | 55 | 0.100 | Why? |  | Referral and Consultation | 1 | 2014 | 292 | 0.100 | Why? |  | Thiazolidinediones | 1 | 2012 | 83 | 0.100 | Why? |  | Chlorophenols | 1 | 2011 | 1 | 0.090 | Why? |  | Fractures, Bone | 1 | 2012 | 107 | 0.090 | Why? |  | Academic Medical Centers | 1 | 2012 | 151 | 0.090 | Why? |  | Health Services Needs and Demand | 2 | 2024 | 159 | 0.090 | Why? |  | Anticonvulsants | 1 | 2012 | 134 | 0.090 | Why? |  | Hypoglycemic Agents | 1 | 2012 | 211 | 0.090 | Why? |  | Infant, Premature | 2 | 2017 | 333 | 0.090 | Why? |  | Infant, Very Low Birth Weight | 1 | 2010 | 48 | 0.080 | Why? |  | Folic Acid | 2 | 2023 | 140 | 0.080 | Why? |  | Cognition | 2 | 2023 | 331 | 0.080 | Why? |  | South America | 2 | 2019 | 3 | 0.080 | Why? |  | Epilepsy | 1 | 2012 | 187 | 0.080 | Why? |  | Asia | 2 | 2019 | 20 | 0.080 | Why? |  | Europe | 2 | 2019 | 87 | 0.080 | Why? |  | North America | 2 | 2019 | 73 | 0.080 | Why? |  | Sex Distribution | 1 | 2009 | 137 | 0.080 | Why? |  | Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 178 | 0.080 | Why? |  | Disease Susceptibility | 1 | 2009 | 95 | 0.080 | Why? |  | Health Surveys | 2 | 2024 | 238 | 0.080 | Why? |  | Fetal Development | 1 | 2009 | 50 | 0.080 | Why? |  | Fetal Growth Retardation | 1 | 2009 | 40 | 0.080 | Why? |  | Nutritional Status | 2 | 2020 | 137 | 0.080 | Why? |  | Morbidity | 1 | 2009 | 145 | 0.070 | Why? |  | Georgia | 3 | 2021 | 42 | 0.070 | Why? |  | Abnormalities, Multiple | 2 | 2019 | 166 | 0.070 | Why? |  | Heart Failure | 1 | 2012 | 565 | 0.060 | Why? |  | Diabetes Mellitus, Type 2 | 1 | 2012 | 560 | 0.060 | Why? |  | Reproducibility of Results | 2 | 2021 | 1229 | 0.060 | Why? |  | DNA Copy Number Variations | 1 | 2025 | 117 | 0.060 | Why? |  | Water Supply | 1 | 2024 | 22 | 0.060 | Why? |  | Genetic Diseases, Inborn | 1 | 2024 | 24 | 0.060 | Why? |  | Analgesia, Epidural | 1 | 2004 | 28 | 0.060 | Why? |  | Analgesia, Obstetrical | 1 | 2004 | 26 | 0.060 | Why? |  | Prescription Drugs | 1 | 2024 | 41 | 0.050 | Why? |  | Prejudice | 1 | 2004 | 37 | 0.050 | Why? |  | Neural Crest | 1 | 2023 | 1 | 0.050 | Why? |  | Cerebral Ventricles | 1 | 2023 | 23 | 0.050 | Why? |  | Calpain | 1 | 2023 | 23 | 0.050 | Why? |  | Workplace | 1 | 2004 | 94 | 0.050 | Why? |  | Homozygote | 1 | 2023 | 59 | 0.050 | Why? |  | Models, Genetic | 1 | 2023 | 169 | 0.050 | Why? |  | Antibodies, Viral | 1 | 2023 | 109 | 0.050 | Why? |  | Vitamins | 1 | 2022 | 64 | 0.050 | Why? |  | Poisson Distribution | 1 | 2022 | 36 | 0.050 | Why? |  | Syndrome | 1 | 2023 | 247 | 0.050 | Why? |  | Aorta | 1 | 2023 | 165 | 0.050 | Why? |  | Universities | 1 | 2023 | 175 | 0.050 | Why? |  | Data Collection | 1 | 2023 | 290 | 0.050 | Why? |  | Mutation, Missense | 1 | 2022 | 108 | 0.050 | Why? |  | Fever | 1 | 2022 | 112 | 0.050 | Why? |  | Stress, Psychological | 1 | 2004 | 273 | 0.050 | Why? |  | Cardiomyopathy, Hypertrophic, Familial | 1 | 2021 | 5 | 0.050 | Why? |  | Cities | 1 | 2021 | 30 | 0.040 | Why? |  | Longitudinal Studies | 1 | 2023 | 747 | 0.040 | Why? |  | Membrane Proteins | 1 | 2023 | 335 | 0.040 | Why? |  | Chromosome Mapping | 1 | 2021 | 154 | 0.040 | Why? |  | Delivery of Health Care | 1 | 2023 | 323 | 0.040 | Why? |  | Nutritive Value | 1 | 2020 | 29 | 0.040 | Why? |  | Sulfur Dioxide | 1 | 2019 | 4 | 0.040 | Why? |  | Laboratories, Hospital | 1 | 2019 | 6 | 0.040 | Why? |  | Abdominal Wall | 1 | 2019 | 13 | 0.040 | Why? |  | Parents | 1 | 2023 | 335 | 0.040 | Why? |  | Jamaica | 1 | 2019 | 7 | 0.040 | Why? |  | Amphetamines | 1 | 2019 | 27 | 0.040 | Why? |  | Particle Size | 1 | 2019 | 82 | 0.040 | Why? |  | Chromosome Aberrations | 1 | 2021 | 297 | 0.040 | Why? |  | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 58 | 0.040 | Why? |  | Bayes Theorem | 1 | 2019 | 121 | 0.040 | Why? |  | Benzodiazepines | 1 | 2019 | 71 | 0.040 | Why? |  | Mortality | 1 | 2019 | 105 | 0.040 | Why? |  | Needs Assessment | 1 | 2020 | 140 | 0.040 | Why? |  | Ear | 1 | 2018 | 17 | 0.040 | Why? |  | Fetus | 1 | 2020 | 194 | 0.040 | Why? |  | Eye Abnormalities | 1 | 2018 | 24 | 0.040 | Why? |  | Hematologic Neoplasms | 1 | 2020 | 106 | 0.040 | Why? |  | Temperature | 1 | 2019 | 183 | 0.040 | Why? |  | Methadone | 1 | 2019 | 183 | 0.040 | Why? |  | Mutation | 1 | 2024 | 1347 | 0.040 | Why? |  | Family | 1 | 2019 | 176 | 0.040 | Why? |  | Cocaine | 1 | 2019 | 177 | 0.040 | Why? |  | Algorithms | 1 | 2022 | 672 | 0.040 | Why? |  | Intestinal Atresia | 1 | 2017 | 5 | 0.040 | Why? |  | Phenotype | 1 | 2021 | 789 | 0.040 | Why? |  | Lung Diseases | 1 | 2018 | 88 | 0.040 | Why? |  | Diet Records | 1 | 2017 | 18 | 0.040 | Why? |  | Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 9 | 0.040 | Why? |  | Vitamin B 6 | 1 | 2017 | 10 | 0.040 | Why? |  | Anti-Bacterial Agents | 1 | 2023 | 807 | 0.040 | Why? |  | Pandemics | 1 | 2022 | 585 | 0.040 | Why? |  | Smoking | 1 | 2021 | 520 | 0.040 | Why? |  | Food Analysis | 1 | 2017 | 28 | 0.030 | Why? |  | Vitamin B 12 | 1 | 2017 | 27 | 0.030 | Why? |  | Buprenorphine | 1 | 2019 | 151 | 0.030 | Why? |  | Choline | 1 | 2017 | 64 | 0.030 | Why? |  | Colon | 1 | 2017 | 104 | 0.030 | Why? |  | Hypertension, Pulmonary | 1 | 2018 | 130 | 0.030 | Why? |  | Epigenesis, Genetic | 1 | 2020 | 406 | 0.030 | Why? |  | Gastrointestinal Tract | 1 | 2017 | 108 | 0.030 | Why? |  | Quebec | 1 | 2016 | 12 | 0.030 | Why? |  | Methionine | 1 | 2017 | 136 | 0.030 | Why? |  | Decision Making | 1 | 2018 | 282 | 0.030 | Why? |  | Monte Carlo Method | 1 | 2016 | 87 | 0.030 | Why? |  | Body Mass Index | 1 | 2019 | 689 | 0.030 | Why? |  | Gene Expression Regulation | 1 | 2020 | 990 | 0.030 | Why? |  | Sensitivity and Specificity | 1 | 2017 | 891 | 0.030 | Why? |  | Neonatal Screening | 1 | 2015 | 49 | 0.030 | Why? |  | Lung | 1 | 2018 | 509 | 0.030 | Why? |  | Databases, Factual | 1 | 2017 | 706 | 0.030 | Why? |  | Severity of Illness Index | 1 | 2017 | 1026 | 0.030 | Why? |  | China | 1 | 2014 | 134 | 0.030 | Why? |  | Analgesics, Opioid | 1 | 2019 | 590 | 0.030 | Why? |  | Oximetry | 1 | 2014 | 66 | 0.030 | Why? |  | Cardiac Surgical Procedures | 1 | 2016 | 321 | 0.030 | Why? |  | Nutrition Surveys | 1 | 2012 | 117 | 0.020 | Why? |  | Biomedical Research | 1 | 2015 | 256 | 0.020 | Why? |  | Critical Illness | 1 | 2014 | 317 | 0.020 | Why? |  | Body Burden | 1 | 2011 | 11 | 0.020 | Why? |  | Epidemiological Monitoring | 1 | 2011 | 14 | 0.020 | Why? |  | Epidemiologic Methods | 1 | 2011 | 46 | 0.020 | Why? |  | Environmental Monitoring | 1 | 2011 | 74 | 0.020 | Why? |  | Prognosis | 1 | 2015 | 2099 | 0.020 | Why? |  | Aged, 80 and over | 1 | 2016 | 3392 | 0.020 | Why? |  | Heart Ventricles | 1 | 2010 | 267 | 0.020 | Why? |  | Treatment Outcome | 1 | 2016 | 5422 | 0.020 | Why? |  | Labor, Obstetric | 1 | 2004 | 43 | 0.010 | Why? |  | Urban Health | 1 | 2004 | 31 | 0.010 | Why? | 
 | 
																	
																		
																			
																					
    Nembhard's Networks
 
Click the "See All" links for more information and interactive visualizations!
 Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH._ Co-Authors  People in Profiles who have published with this person._ Similar People  People who share similar concepts with this person._ 
            
                Same Department   
				People who are also in this person's primary department.
			 |